Lefradafiban

Generic Name: Lefradafiban

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₃H_₂₅N_₃O_₆

CAS Number: 149503-79-7

Unique Ingredient Identifier: 0R4888YXR5

Background: Lefradafiban is an oral platelet glycoprotein IIb/IIIa receptor antagonist being investigated in the treatment of angina.

Indication: For the treatment of unstable angina.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Influence of Clopidogrel on the Pharmacodynamics and Safety of Fradafiban in Healthy Male Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Lefradafiban
Drug: Clopidogrel

First Posted Date: 2014-10-15

Last Posted Date: 2014-10-15

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 14

Registration Number: NCT02265289

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy